Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
Jun 1, 2017
Epigenetic regulation of cardiac hypertrophy by BET acetyl-lysine binding proteins
$150,000.00
Jun 1, 2017
Reorganization of basal ganglia circuits by drugs of abuse
$249,460.00
Jun 1, 2017
Impact of Vedolizumab on immune cell homing to the female reproductive and gastrointestinal mucosa
$135,000.00
Jun 1, 2017
Impact of co-abuse of alcohol and cannabis on cognition: Identifying the roles of the dopamine and endocannabinoid systems
$135,000.00
Jun 1, 2017
Ultrasound-activated microbubbles for targeted, non-viral gene delivery.
$250,000.00
Jun 1, 2017
Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate.
$150,000.00
Jun 1, 2017
Establishing the role of SP140 in inflammatory bowel disease
$249,888.00
Jun 1, 2017
Mechanisms of metaproteome factors in HIV infection risk in young women
$140,000.00
Jun 1, 2017
Mining the Human Microbiome for Novel Therapeutics
$90,000.00
Jun 1, 2017
The use of evidence in priority setting for International Maternal, Newborn and Child Health interventions in Canada, Uganda and Ghana